Why Sequencing Matters More Than Tool Selection
Most published guidance on vision therapy describes individual instruments in isolation. The real clinical gap is not which tools to use, but when and why to transition between them. The validated progression follows a clear arc: monocular, then bi-ocular (when suppression is present), then binocular, and finally dynamic integrated tasks combining vergence, accommodation, and oculomotor skills with sensory-cognitive demands.
The stakes are real. Convergence insufficiency affects approximately 7.98% of the global population, and 80% of studies confirm that office-based vision therapy is the most effective treatment. Missequenced tools, particularly home reinforcement activities assigned before in-office milestones are met, can undermine therapeutic gains. This article provides a phase-by-phase rationale for when and why to move between tool categories, grounded in the CITT-validated framework and current evidence.
Phase 1: Building the Monocular Foundation Before Any Binocular Tool
Monocular accommodative facility work is the prerequisite phase, not an optional warm-up. Skipping it is the single most common sequencing error, and it causes binocular tools to fail for a straightforward reason: the patient cannot isolate the accommodative response from the vergence response. Without that isolation, every binocular instrument produces unreliable clinical data and inconsistent patient performance.
The foundational sequencing principles described by Birnbaum (1993) and Scheiman & Wick apply directly here. Start with larger targets and brief task durations, then progressively reduce target size and extend duration. These principles govern monocular phase tool selection just as they govern later phases.
Measurable advancement criteria matter more than session counts. The 2025 NJ Society of Optometry framework specifies that progression from Level 3 to Level 4 tasks requires positive fusional vergence (PFV) greater than 15Δ and monocular accommodative facility (MAF) of 11 cycles per minute. These are concrete thresholds, not suggestions.
For patients with active suppression, a distinct bi-ocular phase bridges monocular and binocular work. This involves monocular fixation in a binocular field, establishing simultaneous perception before true binocular fusion tasks begin. Skipping this bridge forces the suppressing eye into fusion demands it cannot yet meet, stalling progress or reinforcing suppression patterns.
Phase 2: Introducing the Brock String as a Foundational Binocular Tool
The Brock string, developed by optometrist Frederick W. Brock in the mid-20th century, is classified as a Level 2 binocular tool in the CITT-validated OBVT1 protocol. It is introduced after the monocular foundation is confirmed, not at the start of therapy. This distinction is critical: clinicians who begin therapy with the Brock string are skipping Phase 1 entirely.
Within the CITT 12-week framework, bead placement follows a structured progression. The patient begins at 10 inches (near), advances to 30 inches (mid), and ultimately works at 45 inches (far). Each position creates a distinct step vergence demand. The progression is not arbitrary; it systematically increases the vergence range the patient must control.
The Brock string's defining clinical advantage is physiological diplopia as real-time biofeedback. The characteristic X-pattern at the fixated bead confirms simultaneous binocular input to both the patient and the clinician in the moment it occurs. No other tool at this phase provides such immediate, unambiguous feedback. A 2025 systematic review found insufficient evidence that VR-based tools outperform the Brock string, reinforcing its continued clinical primacy as a foundational vergence training instrument.
Contrast this with the aperture rule's dissociative design, which artificially separates accommodation from vergence. These two instruments serve different phases for different reasons. The Brock string operates in natural space with continuous biofeedback; the aperture rule stress-tests vergence-accommodation independence under artificial dissociation. They are not interchangeable.
Readiness criteria to exit Phase 2: the patient achieves stable physiological diplopia at 45 inches with consistent fusion. Task completion alone is not sufficient. The clinician must observe repeatable, stable performance before advancing.
Phase 3: Advancing to the Aperture Rule and Vectograms
The aperture rule, developed by Vodnoy in 1956, occupies an intermediate-to-advanced position in the sequencing framework. Its 12 convergence levels and 12 divergence levels artificially dissociate accommodation from vergence to automate their interaction. This is a fundamentally different mechanism than the Brock string's natural-space fusion work.
The clinical rationale for introducing dissociation at this phase is specific: once natural-space fusion is stable (confirmed by Phase 2 exit criteria), the aperture rule stress-tests whether vergence and accommodation can operate independently under controlled conditions. The aperture rule trains both smooth (tonic) and jump (phasic) vergence, and it can be combined with prism flippers and lens flippers to increase demand progressively.
Vectograms enter the protocol at this same intermediate-to-advanced phase. These polarized transparent sheets allow the therapist to slide targets and continuously vary vergence demand, either base-in or base-out, in a stepless manner. This continuous adjustment makes vectograms more clinically flexible than fixed-demand instruments like tranaglyphs.
The distinction between vectograms and the aperture rule is important. Vectograms operate in free space with continuous demand variation. The aperture rule is a dissociative, fixed-step instrument. They are complementary, not interchangeable. A complete Phase 3 plan uses both, because each trains vergence control through a different mechanism.
For exotropia patients, the intermediate phase uses bead-string exercises and vectograms at different working distances before the final phase shifts toward near stereopsis, anti-suppression tasks, and fusion-accommodation flexibility work.
Integrating Computer-Based Activities: VTS4 and Beyond
Computer-based orthoptic tools such as VTS4 Random Dot Stereogram (RDS) are listed in the CITT protocol at the same phase as vectograms (Phase 2/3). They serve as a complement or alternative to polarized free-space targets, not a replacement.
The clinical roles are distinct. Vectograms offer continuous vergence demand in free space with direct clinician observation. Computer-based orthopters provide gamified, measurable repetition with built-in data logging. Each fills a gap the other cannot. A 2025 comprehensive review published in PMC confirmed that vision therapy software has produced a significant shift in managing binocular vision disorders, amblyopia, and convergence insufficiency through AI, VR, and AR adaptive environments.
A pilot RCT comparing VR-based vision therapy to traditional office-based vergence/accommodative therapy found both methods effectively improved near point of convergence (NPC) and Sheard's criteria outcomes over a 12-week protocol. This supports hybrid integration rather than an either/or selection.
A practical session structure might look like this:
- Open with Brock string for warm-up and biofeedback confirmation
- Advance to vectogram or aperture rule for primary vergence demand work
- Close with computer-based activity for data capture and gamified reinforcement
Good-Lite's catalog of vision therapy instruments, including polarized targets and computer-based orthoptic tools, supports this hybrid approach across all phases of a treatment plan.
When to Re-Sequence: Managing Plateaus and Regressions
A patient who plateaus mid-protocol is not a treatment failure; it is a sequencing signal. The appropriate response is to return to the last tool at which stable performance was achieved, confirm that performance, and then re-advance.
Plateau indicators include:
- Inconsistent physiological diplopia on the Brock string at a previously mastered distance
- Loss of fusion on vectograms at a previously achieved demand level
- Declining monocular accommodative facility (MAF) scores
The clinical decision tree is straightforward. If regression occurs at the vectogram phase, re-introduce the aperture rule at a lower level before returning to free-space polarized targets. If regression occurs at the aperture rule, revisit the Brock string at mid-distance. Each step back should be brief and targeted, not a full protocol restart.
Adult patients are valid candidates for the full tool progression. A 2025 meta-analysis across 422 adult patients found a significant improvement (SMD -0.68) with perceptual learning, validating the use of advanced sequenced tools in adults well beyond the traditional critical period.
Emerging evidence also supports calibrated sequencing for specific populations. The 2025 CONCUSS RCT extended the evidence base for office-based vision therapy to concussion-related convergence insufficiency, while a 2024 presbyopic RCT addressed sequencing in older adults where accommodative demand tools require different calibration than in pediatric or young adult patients.
Putting It Together: A Phase-by-Phase Sequencing Reference
The following reference maps tools to therapy phases with measurable advancement criteria at each transition:
- Phase 1 (Monocular Foundation): Monocular accommodative facility tools. Advance when MAF reaches 11 cpm and PFV exceeds 15Δ. Bi-ocular tasks are included here for patients with active suppression.
- Phase 2 (Foundational Binocular): Brock string with bead progression from 10 to 45 inches. Advance when stable physiological diplopia is achieved at 45 inches with consistent fusion.
- Phase 3 (Intermediate-Advanced Binocular): Aperture rule, vectograms, and computer-based orthoptic tools (VTS4, Computer Orthopter). Vectograms provide continuous free-space demand; computer-based tools provide data-logged gamified repetition. Both belong in a complete Phase 3 plan because their clinical roles are distinct, not interchangeable.
- Phase 4 (Dynamic Integrated): Near stereopsis, anti-suppression tasks, and fusion-accommodation flexibility work combining vergence, accommodation, and oculomotor skills with sensory-cognitive demands.
Home reinforcement must follow the same sequencing logic. The Brock string is appropriate for Phase 1 and Phase 2 home practice. Computer-based home programs (such as HTS) are appropriate at Phase 3. Assigning advanced home activities before in-office milestones are met undermines the gains built during supervised sessions.
Advancement decisions should always be driven by measurable thresholds (PFV, MAF, NPC) rather than session count alone. The tool is only as effective as the phase it is matched to. Sequencing is the treatment plan.
